Provided by Tiger Trade Technology Pte. Ltd.

Scholar Rock Holding Corp

42.20
0.0000
Post-market: 42.12-0.0800-0.19%19:30 EDT
Volume:3.30M
Turnover:139.40M
Market Cap:5.14B
PE:-12.56
High:43.12
Open:41.87
Low:41.12
Close:42.20
52wk High:61.76
52wk Low:27.07
Shares:121.79M
Float Shares:107.73M
Volume Ratio:1.82
T/O Rate:3.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3601
EPS(LYR):-3.4845
ROE:-167.77%
ROA:-58.82%
PB:20.25
PE(LYR):-12.11

Loading ...

Scholar Rock Reports New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 15

Scholar Rock Holding Price Target Raised to $63.00/Share from $56.00 by JP Morgan

Dow Jones
·
Aug 13

Scholar Rock Holding Price Target Maintained with a $65.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 10

Update: Scholar Rock Holding Says Apitegromab BLA Review Stays on Track for September 30 PDUFA Date

MT Newswires Live
·
Aug 10

Scholar Rock Holding Says Apitegromab BLA Review Stays on Track for September 30 PDUFA Date

MT Newswires Live
·
Aug 08

Scholar Rock Holdings Pulls Novo Nordisk Facility from Drug Application After FDA Flag

Dow Jones
·
Aug 08

Scholar Rock to remove Catalent Indiana facility from apitegromab BLA

TIPRANKS
·
Aug 08

Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD), GH Research (GHRS) and Scholar Rock Holding (SRRK)

TIPRANKS
·
Aug 08

Scholar Rock Drops Catalent Indiana from Apitegromab BLA After FDA Flags Site Inspection as OAI

Reuters
·
Aug 08

Scholar Rock Holding Corporation - to Remove Catalent Indiana Facility from Apitegromab Bla

THOMSON REUTERS
·
Aug 08

Scholar Rock Holding Corporation - Engaging with Ema to Include Second Fill-Finish Facility in Apitegromab Maa

THOMSON REUTERS
·
Aug 08

Scholar Rock Holding Corporation - Prepared for U.S. Apitegromab Launch Immediately upon FDA Approval

THOMSON REUTERS
·
Aug 08

Scholar Rock Announces FDA Review of Apitegromab Biologics License Application (Bla) for Spinal Muscular Atrophy (Sma) to Progress with Second Fill-Finish Facility; Approval Decision Anticipated by September 30, 2026 Action Date

THOMSON REUTERS
·
Aug 08

Analysts Offer Insights on Healthcare Companies: Progyny (PGNY), Scholar Rock Holding (SRRK) and Ascendis Pharma (ASND)

TIPRANKS
·
Aug 08

Scholar Rock Holding Corporation : Bmo Raises Target Price to $76 from $70

THOMSON REUTERS
·
Aug 07

Stock Track | Scholar Rock Soars 10.59% Intraday as Q2 Loss Narrows and FDA Review for Apitegromab Advances

Stock Track
·
Aug 07

Scholar Rock Holding Corporation Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Scholar Rock Files for up to $200 Million At-the-Market Stock Offering

Reuters
·
Aug 06

Scholar Rock Q2 Net Loss Narrows

Reuters
·
Aug 06

Earnings Flash (SRRK) Scholar Rock Posts Q2 Loss of $0.84 a Share, vs. FactSet Est of $0.84 Loss

MT Newswires Live
·
Aug 06